355 related articles for article (PubMed ID: 36463401)
1. Mucosal-associated invariant T cells for cancer immunotherapy.
Li YR; Zhou K; Wilson M; Kramer A; Zhu Y; Dawson N; Yang L
Mol Ther; 2023 Mar; 31(3):631-646. PubMed ID: 36463401
[TBL] [Abstract][Full Text] [Related]
2. Mouse mucosal-associated invariant T cell receptor recognition of MR1 presenting the vitamin B metabolite, 5-(2-oxopropylideneamino)-6-d-ribitylaminouracil.
Ciacchi L; Mak JYW; Le JP; Fairlie DP; McCluskey J; Corbett AJ; Rossjohn J; Awad W
J Biol Chem; 2024 May; 300(5):107229. PubMed ID: 38537698
[TBL] [Abstract][Full Text] [Related]
3. Detection, Expansion, and Isolation of Human MAIT Cells.
Liu Y; Wang W; Wu X; Weng X
Methods Mol Biol; 2020; 2111():285-293. PubMed ID: 31933215
[TBL] [Abstract][Full Text] [Related]
4. Engineering Human MAIT Cells with Chimeric Antigen Receptors for Cancer Immunotherapy.
Dogan M; Karhan E; Kozhaya L; Placek L; Chen X; Yigit M; Unutmaz D
J Immunol; 2022 Oct; 209(8):1523-1531. PubMed ID: 36165183
[TBL] [Abstract][Full Text] [Related]
5. Characterization of Human Mucosal-associated Invariant T (MAIT) Cells.
Souter MNT; Loh L; Li S; Meehan BS; Gherardin NA; Godfrey DI; Rossjohn J; Fairlie DP; Kedzierska K; Pellicci DG; Chen Z; Kjer-Nielsen L; Corbett AJ; McCluskey J; Eckle SBG
Curr Protoc Immunol; 2019 Dec; 127(1):e90. PubMed ID: 31763790
[TBL] [Abstract][Full Text] [Related]
6. The effect of MR1 ligand glyco-analogues on mucosal-associated invariant T (MAIT) cell activation.
Braganza CD; Shibata K; Fujiwara A; Motozono C; Sonoda KH; Yamasaki S; Stocker BL; Timmer MSM
Org Biomol Chem; 2019 Oct; 17(40):8992-9000. PubMed ID: 31497838
[TBL] [Abstract][Full Text] [Related]
7. Mucosal-associated invariant T (MAIT) cells, a new source of universal immune cells for chimeric antigen receptor (CAR)-cell therapy.
Bohineust A; Tourret M; Derivry L; Caillat-Zucman S
Bull Cancer; 2021 Oct; 108(10S):S92-S95. PubMed ID: 34920812
[TBL] [Abstract][Full Text] [Related]
8. Activating Mucosal-Associated Invariant T Cells Induces a Broad Antitumor Response.
Ruf B; Catania VV; Wabitsch S; Ma C; Diggs LP; Zhang Q; Heinrich B; Subramanyam V; Cui LL; Pouzolles M; Evans CN; Chari R; Sakai S; Oh S; Barry CE; Barber DL; Greten TF
Cancer Immunol Res; 2021 Sep; 9(9):1024-1034. PubMed ID: 34193462
[TBL] [Abstract][Full Text] [Related]
9. A molecular basis underpinning the T cell receptor heterogeneity of mucosal-associated invariant T cells.
Eckle SB; Birkinshaw RW; Kostenko L; Corbett AJ; McWilliam HE; Reantragoon R; Chen Z; Gherardin NA; Beddoe T; Liu L; Patel O; Meehan B; Fairlie DP; Villadangos JA; Godfrey DI; Kjer-Nielsen L; McCluskey J; Rossjohn J
J Exp Med; 2014 Jul; 211(8):1585-600. PubMed ID: 25049336
[TBL] [Abstract][Full Text] [Related]
10. Dual TCR-α Expression on Mucosal-Associated Invariant T Cells as a Potential Confounder of TCR Interpretation.
Suliman S; Kjer-Nielsen L; Iwany SK; Lopez Tamara K; Loh L; Grzelak L; Kedzierska K; Ocampo TA; Corbett AJ; McCluskey J; Rossjohn J; León SR; Calderon R; Lecca-Garcia L; Murray MB; Moody DB; Van Rhijn I
J Immunol; 2022 Mar; 208(6):1389-1395. PubMed ID: 35246495
[TBL] [Abstract][Full Text] [Related]
11. MAIT, MR1, microbes and riboflavin: a paradigm for the co-evolution of invariant TCRs and restricting MHCI-like molecules?
Mondot S; Boudinot P; Lantz O
Immunogenetics; 2016 Aug; 68(8):537-48. PubMed ID: 27393664
[TBL] [Abstract][Full Text] [Related]
12. Mucosal-associated invariant T cells in cancer: dual roles, complex interactions and therapeutic potential.
Yigit M; Basoglu OF; Unutmaz D
Front Immunol; 2024; 15():1369236. PubMed ID: 38545100
[TBL] [Abstract][Full Text] [Related]
13. The effects of 5-OP-RU stereochemistry on its stability and MAIT-MR1 axis.
Matsuoka T; Motozono C; Hattori A; Kakeya H; Yamasaki S; Oishi S; Ohno H; Inuki S
Chembiochem; 2021 Feb; 22(4):672-678. PubMed ID: 33034934
[TBL] [Abstract][Full Text] [Related]
14. Human liver CD8
Rha MS; Han JW; Kim JH; Koh JY; Park HJ; Kim SI; Kim MS; Lee JG; Lee HW; Lee DH; Kim W; Park JY; Joo DJ; Park SH; Shin EC
J Hepatol; 2020 Sep; 73(3):640-650. PubMed ID: 32247824
[TBL] [Abstract][Full Text] [Related]
15. Human MAIT Cell Activation In Vitro.
Hagel JP; Garner LC; Bilton M; Mehta H; Leng T; Hackstein CP; Phalora P; Amini A; Akther HD; Provine NM; Edmans M; Willberg CB; Klenerman P
Methods Mol Biol; 2020; 2098():97-124. PubMed ID: 31792818
[TBL] [Abstract][Full Text] [Related]
16. Structural insight into MR1-mediated recognition of the mucosal associated invariant T cell receptor.
Reantragoon R; Kjer-Nielsen L; Patel O; Chen Z; Illing PT; Bhati M; Kostenko L; Bharadwaj M; Meehan B; Hansen TH; Godfrey DI; Rossjohn J; McCluskey J
J Exp Med; 2012 Apr; 209(4):761-74. PubMed ID: 22412157
[TBL] [Abstract][Full Text] [Related]
17. MAIT cells and MR1-antigen recognition.
Keller AN; Corbett AJ; Wubben JM; McCluskey J; Rossjohn J
Curr Opin Immunol; 2017 Jun; 46():66-74. PubMed ID: 28494326
[TBL] [Abstract][Full Text] [Related]
18. MR1 Tetramer-Based Artificial APCs Expand MAIT Cells from Human Peripheral Blood That Effectively Kill Glioblastoma Cells.
Priya R; Brutkiewicz RR
Immunohorizons; 2021 Jun; 5(6):500-511. PubMed ID: 34172533
[TBL] [Abstract][Full Text] [Related]
19. The Immune Modulating Properties of Mucosal-Associated Invariant T Cells.
Ioannidis M; Cerundolo V; Salio M
Front Immunol; 2020; 11():1556. PubMed ID: 32903532
[TBL] [Abstract][Full Text] [Related]
20. The molecular basis for Mucosal-Associated Invariant T cell recognition of MR1 proteins.
López-Sagaseta J; Dulberger CL; Crooks JE; Parks CD; Luoma AM; McFedries A; Van Rhijn I; Saghatelian A; Adams EJ
Proc Natl Acad Sci U S A; 2013 May; 110(19):E1771-8. PubMed ID: 23613577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
